Market Overview:
The global tissue ablation market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in tissue ablation devices, and rising demand for minimally invasive procedures. Oncology is the largest application segment of the global tissue ablation market and is expected to grow at a CAGR of 7.8% from 2018 to 2030. This can be attributed to the increasing incidence of cancer and growing demand for minimally invasive procedures.
Product Definition:
Tissue ablation is the surgical removal of a tissue. The main use for tissue ablation is to remove cancerous tissues from the body.
Radiofrequency Ablation:
Radiofrequency Ablation (RFA) is a minimally invasive surgical procedure used to treat patients suffering from precancerous and cancerous lesions. It uses radio waves or heat energy to destroy the targeted tissue without damaging surrounding areas. RFA has been in use for over two decades and has gained popularity due to its several advantages such as safety, efficacy, time efficiency & cost effectiveness among others.
Ultrasound Ablation:
Ultrasound Ablation is a minimally invasive surgical procedure used to treat patients suffering from varicose veins, spider veins, hemorrhoids and other such conditions. Ultrasound energy is used to destroy the targeted tissue with very little or no damage to the surrounding area. The treatment has several advantages over traditional surgeries such as it’s safe and causes less pain & swelling after completion of surgery. It also offers faster recovery than other treatments available for similar conditions.
Application Insights:
On the basis of application, the global tissue ablation market is segmented into oncology, cardiology, gynecology, cosmetology and urology. The oncology segment dominated the overall market in terms of revenue share in 2017. This can be attributed to a high prevalence of cancer worldwide coupled with increasing number of FDA approvals for various products pertaining to this field. For instance, Xtreme Evolution¢â‚¬â„¢s RF device has been approved by the U.S Food & Drug Administration (FDA) for treatment of prostate cancer and other similar non-cancerous conditions such as benign prostatic hyperplasia (BPH).
The cardiology segment is expected to grow at a lucrative rate during the forecast period owing to an increase in demand for minimally invasive procedures that help reduce patient¢â‚¬â„¢s anxiety levels while offering better cosmetic results than open surgeries do.
Regional Analysis:
North America dominated the global tissue ablation market in 2017 owing to the presence of sophisticated healthcare infrastructure, high adoption rate of advanced technologies and a large number of target population. Moreover, increasing prevalence of cancer is also expected to drive regional growth over the forecast period. The U.S., which accounted for more than 75% share in North America market, is estimated to witness significant growth due to its well-developed healthcare sector and supportive government initiatives pertaining to quality medical care services delivery system development.
Asia Pacific region is anticipated to grow at a lucrative rate during the forecast period owing with rapid economic development coupled with improving healthcare infrastructure in countries such as India and China that are major contributors towards this industry’s expansion including South Korea, Taiwan Province Of China (Taiwan), Singapore etc.; thus making Asia Pacific one of the most promising regions for business opportunities during 2018 - 2030 time span.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for tissue ablation procedures in the coming years.
- Growing awareness about minimally invasive procedures: There is a growing awareness among patients and healthcare professionals about the benefits of minimally invasive procedures over traditional surgery. This is likely to boost the demand for tissue ablation therapies in the coming years.
- Technological advancements: Tissue ablation technologies are constantly evolving, with new and improved devices being launched into the market on a regular basis. This is likely to fuel growth in this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tissue Ablation Market Research Report
By Type
Radiofrequency Ablation, Ultrasound Ablation, Laser-Based Ablation, Irreversible Electroporation, Cryoablation Devices, Microwaves Ablation, Hydrothermal Ablation, External Beam Radiation Therapy (EBRT)
By Application
Oncology, Cardiology, Gynecology, Cosmetology, Urology, Opthalmology
By Companies
Boston Scientific, Johnson & Johnson, Medtronic, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Tissue Ablation Market Report Segments:
The global Tissue Ablation market is segmented on the basis of:
Types
Radiofrequency Ablation, Ultrasound Ablation, Laser-Based Ablation, Irreversible Electroporation, Cryoablation Devices, Microwaves Ablation, Hydrothermal Ablation, External Beam Radiation Therapy (EBRT)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiology, Gynecology, Cosmetology, Urology, Opthalmology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Johnson & Johnson
- Medtronic
- Abbott
Highlights of The Tissue Ablation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiofrequency Ablation
- Ultrasound Ablation
- Laser-Based Ablation
- Irreversible Electroporation
- Cryoablation Devices
- Microwaves Ablation
- Hydrothermal Ablation
- External Beam Radiation Therapy (EBRT)
- By Application:
- Oncology
- Cardiology
- Gynecology
- Cosmetology
- Urology
- Opthalmology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tissue Ablation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tissue ablation is a medical procedure that uses heat, radiation, or chemicals to destroy tissue. Tissue ablation can be used to treat a variety of conditions, including cancer.
Some of the major players in the tissue ablation market are Boston Scientific, Johnson & Johnson, Medtronic, Abbott.
The tissue ablation market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tissue Ablation Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Tissue Ablation Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Tissue Ablation Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Tissue Ablation Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Tissue Ablation Market Size & Forecast, 2018-2028 4.5.1 Tissue Ablation Market Size and Y-o-Y Growth 4.5.2 Tissue Ablation Market Absolute $ Opportunity
Chapter 5 Global Tissue Ablation Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tissue Ablation Market Size Forecast by Type
5.2.1 Radiofrequency Ablation
5.2.2 Ultrasound Ablation
5.2.3 Laser-Based Ablation
5.2.4 Irreversible Electroporation
5.2.5 Cryoablation Devices
5.2.6 Microwaves Ablation
5.2.7 Hydrothermal Ablation
5.2.8 External Beam Radiation Therapy (EBRT)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tissue Ablation Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tissue Ablation Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Gynecology
6.2.4 Cosmetology
6.2.5 Urology
6.2.6 Opthalmology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tissue Ablation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tissue Ablation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tissue Ablation Analysis and Forecast
9.1 Introduction
9.2 North America Tissue Ablation Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tissue Ablation Market Size Forecast by Type
9.6.1 Radiofrequency Ablation
9.6.2 Ultrasound Ablation
9.6.3 Laser-Based Ablation
9.6.4 Irreversible Electroporation
9.6.5 Cryoablation Devices
9.6.6 Microwaves Ablation
9.6.7 Hydrothermal Ablation
9.6.8 External Beam Radiation Therapy (EBRT)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tissue Ablation Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cardiology
9.10.3 Gynecology
9.10.4 Cosmetology
9.10.5 Urology
9.10.6 Opthalmology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tissue Ablation Analysis and Forecast
10.1 Introduction
10.2 Europe Tissue Ablation Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tissue Ablation Market Size Forecast by Type
10.6.1 Radiofrequency Ablation
10.6.2 Ultrasound Ablation
10.6.3 Laser-Based Ablation
10.6.4 Irreversible Electroporation
10.6.5 Cryoablation Devices
10.6.6 Microwaves Ablation
10.6.7 Hydrothermal Ablation
10.6.8 External Beam Radiation Therapy (EBRT)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tissue Ablation Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cardiology
10.10.3 Gynecology
10.10.4 Cosmetology
10.10.5 Urology
10.10.6 Opthalmology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tissue Ablation Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tissue Ablation Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tissue Ablation Market Size Forecast by Type
11.6.1 Radiofrequency Ablation
11.6.2 Ultrasound Ablation
11.6.3 Laser-Based Ablation
11.6.4 Irreversible Electroporation
11.6.5 Cryoablation Devices
11.6.6 Microwaves Ablation
11.6.7 Hydrothermal Ablation
11.6.8 External Beam Radiation Therapy (EBRT)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tissue Ablation Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cardiology
11.10.3 Gynecology
11.10.4 Cosmetology
11.10.5 Urology
11.10.6 Opthalmology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tissue Ablation Analysis and Forecast
12.1 Introduction
12.2 Latin America Tissue Ablation Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tissue Ablation Market Size Forecast by Type
12.6.1 Radiofrequency Ablation
12.6.2 Ultrasound Ablation
12.6.3 Laser-Based Ablation
12.6.4 Irreversible Electroporation
12.6.5 Cryoablation Devices
12.6.6 Microwaves Ablation
12.6.7 Hydrothermal Ablation
12.6.8 External Beam Radiation Therapy (EBRT)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tissue Ablation Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cardiology
12.10.3 Gynecology
12.10.4 Cosmetology
12.10.5 Urology
12.10.6 Opthalmology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tissue Ablation Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tissue Ablation Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tissue Ablation Market Size Forecast by Type
13.6.1 Radiofrequency Ablation
13.6.2 Ultrasound Ablation
13.6.3 Laser-Based Ablation
13.6.4 Irreversible Electroporation
13.6.5 Cryoablation Devices
13.6.6 Microwaves Ablation
13.6.7 Hydrothermal Ablation
13.6.8 External Beam Radiation Therapy (EBRT)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tissue Ablation Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cardiology
13.10.3 Gynecology
13.10.4 Cosmetology
13.10.5 Urology
13.10.6 Opthalmology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tissue Ablation Market: Competitive Dashboard
14.2 Global Tissue Ablation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Johnson & Johnson
14.3.3 Medtronic
14.3.4 Abbott